Exclusive interview for SPINOFF.COM with Dr. Luka Fajs, Eclipse Diagnostics Inc., CEO, about blood-testing medical platform
Eclipse Diagnostics is a biotech company developing a patented device for early stroke (lat. Apoplexia) detection. Strokes are the second cause of death in the US and this device can help 7M stroke patients prevent another stroke. Eclipse Diagnostics are raising capital for the FDA approval process.
The core of stroke home test is a patented testing platform - ELLI - that enables measurement of the levels of disease biomarkers within 15 minutes using only a drop of blood and a single-step procedure. The principle of the technology (that has been peer-reviewed in international journals) is a combination of the underlying technologies of the two most successful tests in the market: pregnancy-test technology and the glucose-test technology, that are merged together with a patented chemical formulation that enables laboratory-grade measurement accuracy at a low cost. The technology originates from Prof. Robert S. Marks's laboratory in the Ben-Gurion University (BGUni) of the Negev and Nanyang Technological University Singapore. The resulting technology enables a rapid and easy-to-use test for detection of stroke biomarkers, infectious disease, and other medical or non-medical conditions.